Since Kanyos Bio was founded in 2014, it has participated in 1 round of funding. In total Kanyos Bio has raised $16.0M. Kanyos Bio's funding round was on Mar 2016 for a total of $16.0M.
Kanyos Bio has 4 investors, including Astellas Pharma Inc, Versant Venture Management LLC and Novartis Venture Fund. The latest investment occurred in Mar 2016.